AstraZeneca and Oxford University have applied for authorisation for their coronavirus vaccine in the European Union with a decision possible by January 29, The European Medicines Agency said on Tuesday.
The jab would be the third available for the 27-nation EU after the Pfizer-BioNTech and Moderna drugs, as the bloc struggles to speed up the rollout.
“EMA has received an application for conditional marketing authorisation for a COVID-19 vaccine developed by AstraZeneca and Oxford University,” the Amsterdam-based regulator said in a statement.
The EMA said its assessment would “proceed under an accelerated timeline”.
- मुख्यमंत्री श्री चौहान ने भजन गायक श्री चंचल के निधन पर शोक व्यक्त किया - January 22, 2021
- गैजेट का इस्तेमाल दिमागी और शारीरिक सेहत को करता है प्रभावित, इस तरह ले सकते हैं डिजिटल ब्रेक - January 22, 2021
- Study examines mono, chronic fatigue syndrome in college students - January 22, 2021
- For Rising Number of People, Obesity Is a Literal Headache - January 22, 2021
- आठ चिटफंड कंपनियाँ बंद - January 22, 2021
- Do You Know Vitamin K May Help You Have Strong Bones? Here Are Major Sources - January 22, 2021
- Allowed Foods on This Bland Diet - January 22, 2021
- Consenting for treatment in advance to reduce leaving the hospital against medical advice among patients with addiction - January 22, 2021
- Team of community pharmacists to start vaccinating housebound patients - January 22, 2021
- Health Highlights: Jan. 22, 2021 - January 22, 2021